News
0
Health secretary says that critics are ‘spreading lies’
0
Will investigate drug’s ability against head and neck cancers
0
Will gain rights to potential blood cancer treatment blinatumomab
Features
In-licensing from cutting edge biotech is now vital to pharma - but lower upfront payments are shifting the balance of risk and reward
Featured Appointment
GlaxoSmithKline has announced that after nine years with the firm, Sir Crispin Davis, Sir Robert Wilson and Larry Culp will stand down from the...
Service Company News
Search Service Company Key Personnel
Featured Event
01/02/2012 - 02/02/2012 -
NA,
